Statements (29)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:biotechnology
|
gptkbp:CEO |
gptkb:Robert_I._Blum
|
gptkbp:collaboratedWith |
gptkb:Amgen
gptkb:Astellas_Pharma |
gptkbp:country |
gptkb:United_States
|
gptkbp:developedBy |
gptkb:aficamten
gptkb:omecamtiv_mecarbil reldesemtiv |
gptkbp:focusesOn |
cardiovascular diseases
muscle biology neuromuscular diseases |
gptkbp:foundedIn |
1997
|
gptkbp:headquartersLocation |
gptkb:South_San_Francisco,_California,_United_States
|
https://www.w3.org/2000/01/rdf-schema#label |
Cytokinetics
|
gptkbp:industry |
gptkb:biotechnology
|
gptkbp:listedOn |
gptkb:NASDAQ
|
gptkbp:notableProduct |
gptkb:aficamten
gptkb:omecamtiv_mecarbil reldesemtiv |
gptkbp:numberOfEmployees |
approximately 300 (2023)
|
gptkbp:researchArea |
gptkb:amyotrophic_lateral_sclerosis_(ALS)
heart failure muscle contractility |
gptkbp:stockSymbol |
gptkb:CYTK
|
gptkbp:tradedOn |
NASDAQ: CYTK
|
gptkbp:type |
gptkb:public_company
|
gptkbp:website |
https://www.cytokinetics.com/
|
gptkbp:bfsParent |
gptkb:South_San_Francisco
|
gptkbp:bfsLayer |
5
|